ACE2 and COVID-19: Nevertheless, advanced age in these two case reports could be an additional risk factor, reducing the immune response against CD and COVID-19.5,24 These may be due to SARS-CoV-2 cell entry receptor expression, angiotensin-converting enzyme-2, immunosenescence, or a larger number of medical comorbidities.25